140 related articles for article (PubMed ID: 36314591)
41. Mutations in γ-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa.
Ralser DJ; Basmanav FB; Tafazzoli A; Wititsuwannakul J; Delker S; Danda S; Thiele H; Wolf S; Busch M; Pulimood SA; Altmüller J; Nürnberg P; Lacombe D; Hillen U; Wenzel J; Frank J; Odermatt B; Betz RC
J Clin Invest; 2017 Apr; 127(4):1485-1490. PubMed ID: 28287404
[TBL] [Abstract][Full Text] [Related]
42. Pathogenicity of POFUT1 mutations in two Chinese families with Dowling-Degos disease.
Li CR; Brooks YS; Jia WX; Wang DG; Xiao XM; Li Q; Li M; Mao QX; Wang B
J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e79-e81. PubMed ID: 26486618
[No Abstract] [Full Text] [Related]
43. Pathogenicity of POFUT1 in Dowling-Degos disease: additional mutations and clinical overlap with reticulate acropigmentation of kitamura.
Buket Basmanav F; Fritz G; Lestringant GG; Pachat D; Hoffjan S; Fischer J; Wehner M; Wolf S; Thiele H; Altmüller J; Pulimood SA; Rütten A; Kruse R; Hanneken S; Frank J; Danda S; Bygum A; Betz RC
J Invest Dermatol; 2015 Feb; 135(2):615-618. PubMed ID: 25229252
[No Abstract] [Full Text] [Related]
44. Heterozygous frameshift mutation in keratin 5 in a family with Galli-Galli disease.
Reisenauer AK; Wordingham SV; York J; Kokkonen EW; Mclean WH; Wilson NJ; Smith FJ
Br J Dermatol; 2014 Jun; 170(6):1362-5. PubMed ID: 24372084
[TBL] [Abstract][Full Text] [Related]
45. Whole-exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling-Degos disease.
Kono M; Sugiura K; Suganuma M; Hayashi M; Takama H; Suzuki T; Matsunaga K; Tomita Y; Akiyama M
Hum Mol Genet; 2013 Sep; 22(17):3524-33. PubMed ID: 23666529
[TBL] [Abstract][Full Text] [Related]
46. Whole exome sequencing in a multi-generation family from India reveals a genetic variation c.10C>T (p.Gln4Ter) in keratin 5 gene associated with Dowling-Degos disease.
Virmani N; Vellarikkal SK; Verma A; Jayarajan R; Sakhiya J; Desai C; Sivasubbu S; Scaria V
Indian J Dermatol Venereol Leprol; 2018; 84(3):344-346. PubMed ID: 29600799
[No Abstract] [Full Text] [Related]
47. Co-occurrence of Dowling-Degos disease and pemphigus vulgaris.
Balighi K; Dastgheib M; Ghannadan A; Qadikolaee PY; Hamzelou S
Int J Dermatol; 2021 Aug; 60(8):e311-e313. PubMed ID: 33660255
[No Abstract] [Full Text] [Related]
48. [Vulvar Dowling-Degos disease].
Hill A; Plantier F; Moyal-Barracco M
Ann Dermatol Venereol; 2020 Sep; 147(8-9):572-574. PubMed ID: 32600663
[No Abstract] [Full Text] [Related]
49. Atypical presentation of Dowling-Degos disease with novel and recurrent mutations in POFUT1.
Zhong W; Liu J; Wang H; Dou X; Yu B; Lin Z; Yang Y
Clin Exp Dermatol; 2018 Dec; 43(8):937-939. PubMed ID: 29797344
[No Abstract] [Full Text] [Related]
50. [Genodermatosis in a pair of brothers: Dowling-Degos, Grover, Darier, Hailey-Hailey or Galli-Galli disease?].
Bardach H; Gebhart W; Luger T
Hautarzt; 1982 Jul; 33(7):378-83. PubMed ID: 7107282
[TBL] [Abstract][Full Text] [Related]
51. Atypical variant of galli-galli disease (grover-like eruption with lentiginous freckling) in a liver transplant patient.
Rongioletti F; Fausti V; Christana K; Montinari M; Parodi A; Fiocca R
Am J Dermatopathol; 2011 Jul; 33(5):504-7. PubMed ID: 21252638
[TBL] [Abstract][Full Text] [Related]
52. A case of co-occurence of Dowling-Degos disease and psoriasis: association or a rarely-seen coincidence?
Topaloglu Demir F; Yontem O; Turkoglu Z; Agirgol S; Kaya H; Ozkok Akbulut T
G Ital Dermatol Venereol; 2018 Dec; 153(6):884-885. PubMed ID: 30518180
[No Abstract] [Full Text] [Related]
53. The deregulation of NOTCH pathway, inflammatory cytokines, and keratinization genes in two Dowling-Degos disease patients with hidradenitis suppurativa.
Cortez Cardoso Penha R; Cortez de Almeida RF; Câmara Mariz J; Brewer Lisboa L; do Nascimento Barbosa L; Souto da Silva R
Am J Med Genet A; 2020 Nov; 182(11):2662-2665. PubMed ID: 33200913
[TBL] [Abstract][Full Text] [Related]
54. Disseminated papular acantholytic dyskeratosis.
Ciupinska M; Kalbarczyk K; Jablonska S
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):55-8. PubMed ID: 9731968
[TBL] [Abstract][Full Text] [Related]
55. Co-existence of leukoderma with features of Dowling-Degos disease: reticulate acropigmentation of Kitamura spectrum in five unrelated patients.
Lestringant GG; Masouyé I; Frossard PM; Adeghate E; Galadari IH
Dermatology; 1997; 195(4):337-43. PubMed ID: 9529553
[TBL] [Abstract][Full Text] [Related]
56. A novel mutation in POFUT1 gene associated with Dowling-Degos disease and hidradenitis suppurativa.
García-Gil MF; Monte Serrano J; Ramirez-Lluch M; Valero Torres A; López-Giménez MT; Lezcano Biosca V
Int J Dermatol; 2021 Jan; 60(1):e25-e27. PubMed ID: 32767357
[No Abstract] [Full Text] [Related]
57. Disseminierte papulöse Variante des Morbus Dowling-Degos: Histopathologische Merkmale bei POGLUT1-Mutation.
Papadopoulou K; Karsai S; Böer-Auer A
J Dtsch Dermatol Ges; 2022 Nov; 20(11):1423-1429. PubMed ID: 36383961
[TBL] [Abstract][Full Text] [Related]
58. Treatment of Dowling-Degos disease with fractional Er:YAG laser.
Yun JH; Kim JH; Choi JS; Roh JY; Lee JR
J Cosmet Laser Ther; 2013 Dec; 15(6):336-9. PubMed ID: 23464495
[TBL] [Abstract][Full Text] [Related]
59. The First Report of KRT5 Mutation Underlying Acantholytic Dowling-Degos Disease with Mottled Hypopigmentation in an Indian Family.
Verma S; Pasternack SM; Rütten A; Ruzicka T; Betz RC; Hanneken S
Indian J Dermatol; 2014 Sep; 59(5):476-80. PubMed ID: 25284854
[TBL] [Abstract][Full Text] [Related]
60. A heterozygous frameshift mutation in the V1 domain of keratin 5 in a family with Dowling-Degos disease.
Liao H; Zhao Y; Baty DU; McGrath JA; Mellerio JE; McLean WH
J Invest Dermatol; 2007 Feb; 127(2):298-300. PubMed ID: 16917491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
